The 13th International Conference on Biomedical Engineering and Biotechnology (ICBEB 2024) will take place in Singapore during November 12-15, 2024.

As an annual conference held successfully in the past 12 years in Macao (ICBEB 2012), Wuhan (ICBEB 2013), Beijing (ICBEB 2014), Shanghai (ICBEB 2015), Hangzhou (ICBEB 2016), Guangzhou (ICBEB 2017), Nanjing (ICBEB 2018), Republic of Korea (ICBEB 2019), Online via Microsoft Teams (ICBEB 2020, ICBEB 2021 and ICBEB 2022), and in Macao (ICBEB 2023), ICBEB serves to foster communication among researchers and practitioners working in a wide variety of scientific areas with a common interest in all fields of Biomedical Engineering and Biotechnology, and provides an extensive platform for the attendees to present diverse perspectives and empirical studies that illuminate recent trends, challenges, and issues in biomedical practices. In combination with a keynote forum, invited and oral presentations, poster presentations, and panel discussions, ICBEB 2024 will also welcome exhibitions.

Singapore is a sunny, tropical island in Southeast Asia, off the southern tip of the Malay Peninsula. It is known as a City in a Garden and nearly 50 percent of the island is green space. It is a thriving metropolis offering a world-class infrastructure, a fully integrated island-wide transport network, dynamic business environment, vibrant living spaces and a rich culture largely influenced by the four major communities in Singapore with each offering different perspective of life in Singapore in terms of culture, religion, food, language and history. Whether it's the arts and cultural exchanges, the creation of cutting-edge innovation to enrich the lives of the communities at home or abroad, or the coming together of world-class minds to spark new business opportunities locally and internationally, Singapore is simply, the place where worlds meet.

On behalf of the organizing committee, we cordially invite all of you to participate in ICBEB 2024 and enjoy the multicultural diversity in Singapore!

 Important Dates

Time Countdown 0 Days Left

Final-Round Submission Deadline:
Extended to October 10, 2024

Sponsors


 Sponsor

Files Download

Frontiers in Bioengineering and Biotechnology: Preclinical Cell and Gene Therapy

Frontiers in Bioengineering and Biotechnology
JCR IF: 4.3
ISSN (electronic): 2296-4185

Frontiers in Public Health

Frontiers in Public Health
JCR IF: 3.0
ISSN (electronic): 2296-2565
Research Topic: Greening Urban Spaces and Human Health, Volume III

BMC Bioinformatics

BMC Bioinformatics
JCR IF: 2.9
ISSN: 1471-2105
Publication Type: Supplement issue

Technology in Cancer Research & Treatment

Technology in Cancer Research & Treatment
JCR IF: 2.7
e-ISSN: 1533-0338

Special issue:Cutting-Edge Developments in Cancer Detection, Diagnosis, and Therapeutic Interventions

Technology and Health Care

Technology and Health Care
JCR IF: 1.4
e-ISSN: 1878-7401
Publication Type: Supplement issue

Preparative Biochemistry & Biotechnology

Preparative Biochemistry & Biotechnology
JCR IF: 2.0
e-ISSN: 1532-2297
Publication Type: Special issue

Preparative Biochemistry & Biotechnology
ISSN (online): 1757-6334
Publication Type: Special issue
Molecular & Cellular Biomechanics
Indexed: Ei Compendex, Scopus, CNKI Scholar, Google Scholar, ResearchGate etc.
* More SCI journals related to ICBEB 2024 General Topics, please contact the organizing committee.

Congratulations! The following 3 Best Oral Presentations and 2 Best Poster Presentations were selected from ICBEB 2023:

Best Oral Awards
1. Dr. Mengxiao Wang, Shanghai Jiao Tong University, China
Session 1: Medical Imaging Technology and Biomedical Signal Processing
Presented Title: Interpretable Deep Learning Model for Identifying the Immediate Risk of Myocardial Infarction Complications

2. Assoc. Prof. Wencheng Zhang, Shanghai East Hospital Affiliated to Tongji University, China
Session 2: Cell biology & Medicinal Chemistry
Presented Title: Patch Grafting of Stem Cell Organoids into the Liver and Pancreas to Rescue the Diseases States

3. Ms. Anwei Zhou, Nanjing University, China
Session 3: Biomechanical Engineering & Biotechnology
Presented Title: Bioengineered Neutrophil Extinguisher Targets Cascade Immune Pathways of Macrophages for Alleviating Cytokine Storm in Pneumonia

Best Poster Awards
1. Ms. Yuanqing Cao, Tongji University, China
Presented Title: Modeling Early Human Cortical Development and Neurotoxicity with a Forebrain Organoid System

2. Assoc. Prof. Qingyuan Zheng, Southeast University, China
Presented Title: High-performance Reconstruction of Undersampled MR Images with Combined Optimization Algorithm and CNN

1. ICBEB 2024 was successfully held in Singapore from November 12-15, 2024. The organizing committee would like to extend their sincere gratitude to all participants for their strong support. Their contributions were instrumental in making the event a great success. ICBEB 2025 is scheduled for November 4-7, 2025, in Matsue, Japan. We welcome everyone to join the conference next year in Japan! [2024-11-25]

2. Welcome BMEF as a Sponsor joining ICBEB! The Open Access journal BMEF, published in association with SIBET CAS, is a platform for the multidisciplinary community of biomedical engineering, publishing wide-ranging research in the field. [2024-9-10]

3. Papers recommended by ICBEB for publication in Technology and Health Care have been indexed in the Science Citation Index Expanded database. [2024-8-9]

4. The special collection entitled 'Cutting-Edge Developments in Cancer Detection, Diagnosis, and Therapeutic Interventions' in the journal Technology in Cancer Research & Treatment (JCR Impact Factor: 2.7) is currently welcoming submissions. [2024-7-1]

5. Welcome IMT Analytics AG as an exhibitor at ICBEB 2024. [2024-6-12]

6. The articles recommended by ICBEB to the SCI journal Technology and Health Care have been published up to Volume 32, Issue S1. [2024-6-4]

7. With effect from 9 February 2024, holders of ordinary passports issued by the People's Republic of China (PRC) will be exempted from visa requirements for a stay of up to 30 days in Singapore. [2024-1-25]


Wechat:wechat  WhatsAPP:wechat
Linked in:linked in